Table 6.
Respondents' attitudes about agonist medication
| Buprenorphine N=90 | Methadone N=88 | |||||
|---|---|---|---|---|---|---|
| Agree | Uncertain | Disagree | Agree | Uncertain | Disagree | |
| N (%)* | N (%)* | N (%)* | N (%)* | N (%)* | N (%)* | |
| Reduces relapse | 42 (45) | 43 (48) | 5 (7) | 39 (44) | 31 (36) | 18 (20) |
| Helps reduce crime and re-incarceration | 37 (41) | 46 (50) | 7 (9) | 36 (41) | 35 (40) | 17 (19) |
| Rewards criminals for being drug users | 8 (10) | 36 (42) | 46 (48) | 15 (22) | 28 (31) | 45 (47) |
| Prolongs addiction | 20 (21) | 43 (49) | 27 (30) | 32 (38) | 36 (38) | 20 (24) |
| Should be used to maintain clients [drug court participants] who are already opioid addicted. | 30 (31) | 40 (47) | 20 (22) | 26 (26) | 30 (40) | 32 (34) |
| More effective than non-pharmacological approaches in retaining patients in treatment | 16 (16) | 54 (58) | 20 (26) | 11 (11) | 49 (54) | 28 (35) |
| Interferes with the ability to drive a car | 4 (4) | 55 (61) | 31 (34) | 11 (13) | 54 (63) | 23 (24) |
| Reduces or blocks the effects of heroin | 39 (41) | 48 (56) | 3 (3) | 41 (42) | 36 (45) | 11 (13) |
*
all percentages weighted to account for over/underrepresentation of courts in rural, suburban, and urban regions.